Although the role of prostanoids in itch was actively studied a decade ago, interest in this area has waned in recent years. Andoh et al. (2007, this issue) demonstrate that the prostanoid thromboxane A2 elicits scratching through its TP receptor. Identification of new itch mediators and their respective receptors within the skin will undoubtedly be the focus of future drug development for this distressing symptom
Prostaglandin D2 (PGD2) is known to have antipruritic activity by suppressing histamine release. How...
Pruritus, the most common cutaneous symptom, is widely seen in many skin complaints. It is an uncomf...
Pruritus in eczema and other inflammatory skin diseases is an unsolved problem. Recent findings stro...
Although the role of prostanoids in itch was actively studied a decade ago, interest in this area ha...
For centuries, itch was categorized as a submodality of pain. Recent research over the last decade h...
Itch (pruritus) is one of the most often seen sensory phenomena in clinical practice. Recent neuroph...
Itching is the predominant symptom of inflammatory skin diseases. Present evidence indicates that hi...
While the enormous clinical and psychosocial importance of pruritus in many areas of medicine and th...
Although acute itch has a protective role by removing irritants to avoid further damage, chronic itc...
Itch (pruritus) is one of the most often seen sensory phenomena in clinical practice. Recent neuroph...
Transient Receptor Potential (TRP) channels are multifunctional sensory molecules that are abundant ...
Thromboxane A2 (TXA2), a metabolite of arachidonic acid produced by cyclooxygenase and thromboxane s...
Abstract: Itch (pruritus) is one of the most often seen sensory phenomena in clinical practice. Rece...
Transient receptor potential vanilloid type 1 (TRPV1) is found on sensory neurons, keratinocytes, se...
Acute itch (pruritus) is unpleasant and acts as an alerting mechanism for removing irritants. Howeve...
Prostaglandin D2 (PGD2) is known to have antipruritic activity by suppressing histamine release. How...
Pruritus, the most common cutaneous symptom, is widely seen in many skin complaints. It is an uncomf...
Pruritus in eczema and other inflammatory skin diseases is an unsolved problem. Recent findings stro...
Although the role of prostanoids in itch was actively studied a decade ago, interest in this area ha...
For centuries, itch was categorized as a submodality of pain. Recent research over the last decade h...
Itch (pruritus) is one of the most often seen sensory phenomena in clinical practice. Recent neuroph...
Itching is the predominant symptom of inflammatory skin diseases. Present evidence indicates that hi...
While the enormous clinical and psychosocial importance of pruritus in many areas of medicine and th...
Although acute itch has a protective role by removing irritants to avoid further damage, chronic itc...
Itch (pruritus) is one of the most often seen sensory phenomena in clinical practice. Recent neuroph...
Transient Receptor Potential (TRP) channels are multifunctional sensory molecules that are abundant ...
Thromboxane A2 (TXA2), a metabolite of arachidonic acid produced by cyclooxygenase and thromboxane s...
Abstract: Itch (pruritus) is one of the most often seen sensory phenomena in clinical practice. Rece...
Transient receptor potential vanilloid type 1 (TRPV1) is found on sensory neurons, keratinocytes, se...
Acute itch (pruritus) is unpleasant and acts as an alerting mechanism for removing irritants. Howeve...
Prostaglandin D2 (PGD2) is known to have antipruritic activity by suppressing histamine release. How...
Pruritus, the most common cutaneous symptom, is widely seen in many skin complaints. It is an uncomf...
Pruritus in eczema and other inflammatory skin diseases is an unsolved problem. Recent findings stro...